Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022

SELL
$243.64 - $270.48 $545,509 - $605,604
-2,239 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$230.08 - $250.94 $32,211 - $35,131
-140 Reduced 5.88%
2,239 $563,000
Q3 2021

Oct 29, 2021

SELL
$232.72 - $256.47 $346,752 - $382,140
-1,490 Reduced 38.51%
2,379 $585,000
Q2 2021

Aug 09, 2021

SELL
$232.65 - $254.58 $32,571 - $35,641
-140 Reduced 3.49%
3,869 $941,000
Q1 2021

May 06, 2021

SELL
$232.09 - $256.88 $172,907 - $191,375
-745 Reduced 15.67%
4,009 $975,000
Q4 2020

Feb 11, 2021

SELL
$221.92 - $245.94 $8,432 - $9,345
-38 Reduced 0.79%
4,754 $1.19 Million
Q3 2020

Nov 05, 2020

SELL
$215.77 - $276.76 $27,402 - $35,148
-127 Reduced 2.58%
4,792 $1.12 Million
Q2 2020

Aug 04, 2020

SELL
$219.9 - $263.41 $250,905 - $300,550
-1,141 Reduced 18.83%
4,919 $1.18 Million
Q1 2020

Apr 29, 2020

BUY
$195.69 - $279.01 $1.19 Million - $1.69 Million
6,060 New
6,060 $1.39 Million
Q2 2019

Aug 01, 2019

SELL
$217.4 - $246.08 $1.26 Million - $1.43 Million
-5,815 Closed
0 $0
Q1 2019

May 03, 2019

BUY
$206.05 - $248.17 $1.2 Million - $1.44 Million
5,815 New
5,815 $1.45 Million
Q2 2018

Aug 13, 2018

SELL
$208.1 - $233.85 $987,434 - $1.11 Million
-4,745 Closed
0 $0
Q1 2018

May 01, 2018

SELL
$205.46 - $240.27 $567,275 - $663,385
-2,761 Reduced 36.78%
4,745 $1.03 Million
Q4 2017

Jan 29, 2018

BUY
$189.0 - $222.64 $392,364 - $462,200
2,076 Added 38.23%
7,506 $1.61 Million
Q3 2017

Nov 09, 2017

SELL
$186.89 - $198.9 $9,344 - $9,945
-50 Reduced 0.91%
5,430 $1.06 Million
Q2 2017

Aug 07, 2017

BUY
N/A
5,480
5,480 $1.07 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Twin Capital Management Inc Portfolio

Follow Twin Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Twin Capital Management Inc with notifications on news.